Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129
about
The role of maintenance therapy in acute promyelocytic leukemia in the first complete remissionAcute Promyelocytic Leukemia (APL): Comparison Between Children and AdultsTargeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinomaBiology, risk stratification, and therapy of pediatric acute leukemias: an update.Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.Retrospective analysis of 119 cases of pediatric acute promyelocytic leukemia: Comparisons of four treatment regimes.Same sibling marrow following cord allogeneic transplantation as therapy for second relapse acute promyelocytic leukemia in a pediatric patient.How I treat children and adolescents with acute promyelocytic leukaemia.Induction treatments for acute promyelocytic leukemia: a network meta-analysis.Recent advances in the diagnosis and management of childhood acute promyelocytic leukemiaAll-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.
P2860
Q24200224-6B785847-5418-4D04-BA44-EC1F18709423Q27009433-440FE69B-8551-4034-B0FC-195BC4843C81Q28476545-EAE48DFC-11EC-4968-8BD9-1521656703E4Q34764504-61291469-FF1F-44E0-BA8B-BE48DC0AD68CQ35667279-3F0F8134-14C3-4714-94F1-D43336DECD7CQ36053792-CFBAEDA3-929D-428E-8B1A-4B91D7E28F92Q36285651-BF154425-344C-4ED8-9E0C-B8D25953FE4BQ36729327-BF0F0CF3-1A52-4A4D-8AD6-55A6B3EADD7CQ37451376-8B35D1DA-0F56-468C-9566-4E1FA3175610Q37687750-C47A852A-E916-4644-99D8-FCA3C82D1C26Q37899041-95E26B9A-C5CB-4DEF-8EC0-94FC3ED5C69BQ38055497-BDC34F7C-85EF-40EB-9EEA-C039783B1BA4Q38232465-4787ABC9-A85A-40D2-A56F-0735CA93CC2DQ46165728-480F4D10-3517-4730-B710-F2BAFC01D4CA
P2860
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Treatment of children with acu ...... rican Intergroup trial INT0129
@ast
Treatment of children with acu ...... rican Intergroup trial INT0129
@en
type
label
Treatment of children with acu ...... rican Intergroup trial INT0129
@ast
Treatment of children with acu ...... rican Intergroup trial INT0129
@en
prefLabel
Treatment of children with acu ...... rican Intergroup trial INT0129
@ast
Treatment of children with acu ...... rican Intergroup trial INT0129
@en
P2093
P2860
P356
P1476
Treatment of children with acu ...... rican Intergroup trial INT0129
@en
P2093
Charles Schiffer
Cheryl Willman
Haesook Kim
Howard Weinstein
Jacob Rowe
James Feusner
John Gregory
Lois Shepherd
Peter Wiernik
Rob Gerbing
P2860
P304
P356
10.1002/PBC.22165
P577
2009-12-01T00:00:00Z